Sovenyr
Subscribe
Signal
2026-08-02
NIH RePORTER
Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development
Part of
HIV Testing And Treatment Outcomes
Open primary source
Read on Substack